{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:26:45Z","timestamp":1788323205302,"version":"build-2803163510"},"reference-count":118,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T00:00:00Z","timestamp":1663113600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008667","name":"SENSHIN Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008667","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The complement system is part of the innate immune system. The crucial step in activating the complement system is the generation and regulation of C3 convertase complexes, which are needed to generate opsonins that promote phagocytosis, to generate C3a that regulates inflammation, and to initiate the lytic terminal pathway through the generation and activity of C5 convertases. A growing body of evidence has highlighted the interplay between the complement system, coagulation system, platelets, neutrophils, and endothelial cells. The kidneys are highly susceptible to complement-mediated injury in several genetic, infectious, and autoimmune diseases. Atypical hemolytic uremic syndrome (aHUS) and lupus nephritis (LN) are both characterized by thrombosis in the glomerular capillaries of the kidneys. In aHUS, congenital or acquired defects in complement regulators may trigger platelet aggregation and activation, resulting in the formation of platelet-rich thrombi in the kidneys. Because glomerular vasculopathy is usually noted with immunoglobulin and complement accumulation in LN, complement-mediated activation of tissue factors could partly explain the autoimmune mechanism of thrombosis. Thus, kidney glomerular capillary thrombosis is mediated by complement dysregulation and may also be associated with complement overactivation. Further investigation is required to clarify the interaction between these vascular components and develop specific therapeutic approaches.<\/jats:p>","DOI":"10.3389\/fimmu.2022.981375","type":"journal-article","created":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T07:15:53Z","timestamp":1663139753000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["The role of the complement system in kidney glomerular capillary thrombosis"],"prefix":"10.3389","volume":"13","author":[{"given":"Yoko","family":"Yoshida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Nishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00262","article-title":"Roumenina, LT: Complement system part I - molecular mechanisms of activation and regulation","volume":"6","author":"Merle","year":"2015","journal-title":"Front Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1998.00130.x","article-title":"Complement regulatory proteins in glomerular diseases","volume":"54","author":"Nangaku","year":"1998","journal-title":"Kidney Int"},{"key":"B3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/labinvest.2010.173","article-title":"Dynamic control of the complement system by modulated expression of regulatory proteins","volume":"91","author":"Thurman","year":"2011","journal-title":"Lab Invest"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1797.2010.01373.x","article-title":"Review: Complement and its regulatory proteins in kidney diseases","volume":"15","author":"Lesher","year":"2010","journal-title":"Nephrol (Carlton)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2005.06.014","article-title":"Strategies of therapeutic complement inhibition","volume":"43","author":"Mollnes","year":"2006","journal-title":"Mol Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2013.08.008","article-title":"Complement regulation in renal disease models","volume":"33","author":"Naik","year":"2013","journal-title":"Semin Nephrol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.115","article-title":": Novel evidence that crosstalk between the complement, coagulation and fibrinolysis proteolytic cascades is involved in mobilization of hematopoietic stem\/progenitor cells (HSPCs)","volume":"28","author":"Borkowska","year":"2014","journal-title":"Leukemia"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1160\/TH13-02-0102","article-title":"Crosstalk between platelets and the complement system in immune protection and disease","volume":"110","author":"Verschoor","year":"2013","journal-title":"Thromb Haemost"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2007.02.006","article-title":"Complement and coagulation: Strangers or partners in crime","volume":"28","author":"Markiewski","year":"2007","journal-title":"Trends Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.smim.2018.01.003","article-title":"Complement links platelets to innate immunity","volume":"37","author":"Nording","year":"2018","journal-title":"Semin Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15476","article-title":"Complement, inflammation and thrombosis","volume":"178","author":"Rawish","year":"2021","journal-title":"Br J Pharmacol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-11-749879","article-title":"Distinct contributions of complement factors to platelet activation and fibrin formation in venous thrombus development","volume":"129","author":"Subramaniam","year":"2017","journal-title":"Blood"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035690","article-title":"Effects of MASP-1 of the complement system on activation of coagulation factors and plasma clot formation","volume":"7","author":"Hess","year":"2012","journal-title":"PloS One"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0000623","article-title":"Simultaneous activation of complement and coagulation by MBL-associated serine protease 2","volume":"2","author":"Krarup","year":"2007","journal-title":"PloS One"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1655974","article-title":"C5a induces tissue factor activity on endothelial cells","volume":"77","author":"Ikeda","year":"1997","journal-title":"Thromb Haemost"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117430","article-title":"C5a-induced expression of p-selectin in endothelial cells","volume":"94","author":"Foreman","year":"1994","journal-title":"J Clin Invest"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903678","article-title":"Molecular intercommunication between the complement and coagulation systems","volume":"185","author":"Amara","year":"2010","journal-title":"J Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/nm1419","article-title":"Generation of C5a in the absence of C3: A new complement activation pathway","volume":"12","author":"Huber-Lang","year":"2006","journal-title":"Nat Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.323287","article-title":"Plasminogen is a complement inhibitor","volume":"287","author":"Barthel","year":"2012","journal-title":"J Biol Chem"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2000398","article-title":"Cross-talk between the complement pathway and the contact activation system of coagulation: Activated factor XI neutralizes complement factor h","volume":"206","author":"Puy","year":"2021","journal-title":"J Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1084\/jem.150.3.633","article-title":"Human complement in thrombin-mediated platelet function: uptake of the C5b-9 complex","volume":"150","author":"Polley","year":"1979","journal-title":"J Exp Med"},{"key":"B22","article-title":"Functional C8 associated with human platelets","volume":"66","author":"Tedesco","year":"1986","journal-title":"Clin Exp Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/28.1.86-b","article-title":"Rheumatoid arthritis and senile dementia of the alzheimer\u2019s type","volume":"28","author":"Jenkinson","year":"1989","journal-title":"Br J Rheumatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018812","article-title":"Requirements for membrane attack complex formation and anaphylatoxins binding to collagen-activated platelets","volume":"6","author":"Martel","year":"2011","journal-title":"PloS One"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1084\/jem.178.2.579","article-title":"Platelet activation by C1q results in the induction of alpha IIb\/beta 3 integrins (GPIIb-IIIa) and the expression of p-selectin and procoagulant activity","volume":"178","author":"Peerschke","year":"1993","journal-title":"J Exp Med"},{"key":"B26","doi-asserted-by":"crossref","DOI":"10.1016\/S0021-9258(17)39556-X","article-title":"Effect of complement proteins C5b-9 on blood platelets. evidence for reversible depolarization of membrane potential","volume":"260","author":"Wiedmer","year":"1985","journal-title":"J Biol Chem"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1084\/jem.158.2.603","article-title":"Human platelet activation by C3a and C3a des-arg","volume":"158","author":"Polley","year":"1983","journal-title":"J Exp Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2008.03034.x","article-title":"Complement activation triggered by chondroitin sulfate released by thrombin receptor-activated platelets","volume":"6","author":"Hamad","year":"2008","journal-title":"J Thromb Haemost"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1080\/09537100701777311","article-title":"Expression of complement components and inhibitors on platelet microparticles","volume":"19","author":"Yin","year":"2008","journal-title":"Platelets"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20041497","article-title":"Platelet activation leads to activation and propagation of the complement system","volume":"201","author":"Del Conde","year":"2005","journal-title":"J Exp Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1172\/JCI111680","article-title":"Platelet C1- inhibitor. A secreted alpha-granule protein","volume":"75","author":"Schmaier","year":"1985","journal-title":"J Clin Invest"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.84.16.5873","article-title":"Regulation of the activity of platelet-bound C3 convertase of the alternative pathway of complement by platelet factor h","volume":"84","author":"Devine","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2015.04.006","article-title":"The membrane attack complex as an inflammatory trigger","volume":"221","author":"Morgan","year":"2016","journal-title":"Immunobiology"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(94)00463-3","article-title":"Activation of human neutrophils by C3a and C5A. comparison of the effects on shape changes, chemotaxis, secretion, and respiratory burst","volume":"346","author":"Ehrengruber","year":"1994","journal-title":"FEBS Lett"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00467","article-title":"Neutrophil-mediated phagocytosis of staphylococcus aureus","volume":"5","author":"van Kessel","year":"2014","journal-title":"Front Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1100450","article-title":"Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus","volume":"187","author":"Villanueva","year":"2011","journal-title":"J Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-12-401133","article-title":"Endocytosis of soluble immune complexes leads to their clearance by FcgammaRIIIB but induces neutrophil extracellular traps via FcgammaRIIA in vivo","volume":"120","author":"Chen","year":"2012","journal-title":"Blood"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-05-089821","article-title":"Activator-specific requirement of properdin in the initiation and amplification of the alternative pathway complement","volume":"111","author":"Kimura","year":"2008","journal-title":"Blood"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00137","article-title":"NETosing neutrophils activate complement both on their own NETs and bacteria via alternative and non-alternative pathways","volume":"7","author":"Yuen","year":"2016","journal-title":"Front Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2847","article-title":"Infection-induced NETosis is a dynamic process involving neutrophil multitasking in vivo","volume":"18","author":"Yipp","year":"2012","journal-title":"Nat Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"11037","DOI":"10.1038\/ncomms11037","article-title":"Coagulation induced by C3aR-dependent NETosis drives protumorigenic neutrophils during small intestinal tumorigenesis","volume":"7","author":"Guglietta","year":"2016","journal-title":"Nat Commun"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/jre.12284","article-title":"Influence of complement on neutrophil extracellular trap release induced by bacteria","volume":"51","author":"Palmer","year":"2016","journal-title":"J Periodontal Res"},{"key":"B44","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.molimm.2016.02.011","article-title":"Complement factor h modulates the activation of human neutrophil granulocytes and the generation of neutrophil extracellular traps","volume":"72","author":"Schneider","year":"2016","journal-title":"Mol Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00671","article-title":"Factor h binds to extracellular DNA traps released from human blood monocytes in response to candida albicans","volume":"7","author":"Halder","year":"2016","journal-title":"Front Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1102404","article-title":"Neutrophil extracellular traps that are not degraded in systemic lupus erythematosus activate complement exacerbating the disease","volume":"188","author":"Leffler","year":"2012","journal-title":"J Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-3402731","article-title":"Traps n\u2019 clots: NET-mediated thrombosis and related diseases","volume":"120","author":"Stakos","year":"2020","journal-title":"Thromb Haemost"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1172\/JCI141374","article-title":"Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis","volume":"130","author":"Skendros","year":"2020","journal-title":"J Clin Invest"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1312353","article-title":"Syndromes of thrombotic microangiopathy","volume":"371","author":"George","year":"2014","journal-title":"N Engl J Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-10-709857","article-title":"Thrombotic thrombocytopenic purpura","volume":"129","author":"Joly","year":"2017","journal-title":"Blood"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2012.196","article-title":"Renal and neurological involvement in typical shiga toxin-associated HUS","volume":"8","author":"Trachtman","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2013.08.003","article-title":"Atypical hemolytic uremic syndrome","volume":"33","author":"Kavanagh","year":"2013","journal-title":"Semin Nephrol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"99","DOI":"10.5551\/jat.RV17026","article-title":"Pathogenesis of atypical hemolytic uremic syndrome","volume":"26","author":"Yoshida","year":"2019","journal-title":"J Atheroscler Thromb"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome","volume":"368","author":"Legendre","year":"2013","journal-title":"N Engl J Med"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.423","article-title":"Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies","volume":"87","author":"Licht","year":"2015","journal-title":"Kidney Int"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.01.035","article-title":"The long-acting C5 inhibitor, ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naive to complement inhibitor treatment","volume":"97","author":"Rondeau","year":"2020","journal-title":"Kidney Int"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.10.046","article-title":"The long-acting C5 inhibitor, ravulizumab, is effective and safe in pediatric patients with atypical hemolytic uremic syndrome naive to complement inhibitor treatment","volume":"100","author":"Ariceta","year":"2021","journal-title":"Kidney Int"},{"key":"B58","article-title":"Genetic atypical hemolytic-uremic syndrome","volume-title":"GeneReviews","author":"Noris","year":"2021"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2004.01.003","article-title":"Functional analysis in serum from atypical hemolytic uremic syndrome patients reveals impaired protection of host cells associated with mutations in factor h","volume":"41","author":"Sanchez-Corral","year":"2004","journal-title":"Mol Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0124655","article-title":"A novel quantitative hemolytic assay coupled with restriction fragment length polymorphisms analysis enabled early diagnosis of atypical hemolytic uremic syndrome and identified unique predisposing mutations in Japan","volume":"10","author":"Yoshida","year":"2015","journal-title":"PloS One"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-09-109876","article-title":"Factor h autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1\/CFHR3 deficiency","volume":"111","author":"Jozsi","year":"2008","journal-title":"Blood"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-11-709865","article-title":"HUS and atypical HUS","volume":"129","author":"Jokiranta","year":"2017","journal-title":"Blood"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0902814","article-title":"Atypical hemolytic-uremic syndrome","volume":"361","author":"Noris","year":"2009","journal-title":"N Engl J Med"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.5551\/jat.49494","article-title":"Profiles of coagulation and fibrinolysis activation-associated molecular markers of atypical hemolytic uremic syndrome in the acute phase","volume":"27","author":"Sakurai","year":"2020","journal-title":"J Atheroscler Thromb"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0810739","article-title":"Conway, EM: Thrombomodulin mutations in atypical hemolytic-uremic syndrome","volume":"361","author":"Delvaeye","year":"2009","journal-title":"N Engl J Med"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2590","article-title":"Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome","volume":"45","author":"Lemaire","year":"2013","journal-title":"Nat Genet"},{"key":"B67","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1681\/ASN.2013050453","article-title":"Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome","volume":"25","author":"Bu","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.04760512","article-title":"Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults","volume":"8","author":"Fremeaux-Bacchi","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-02-071472","article-title":"Anti factor h autoantibodies block c-terminal recognition function of factor h in hemolytic uremic syndrome","volume":"110","author":"Jozsi","year":"2007","journal-title":"Blood"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.02210310","article-title":"Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype","volume":"5","author":"Noris","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M900814200","article-title":"Mutations of factor h impair regulation of surface-bound C3b by three mechanisms in atypical hemolytic uremic syndrome","volume":"284","author":"Lehtinen","year":"2009","journal-title":"J Biol Chem"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2014.08.005","article-title":"The role of heparan sulfate as determining pathogenic factor in complement factor h-associated diseases","volume":"63","author":"Loeven","year":"2015","journal-title":"Mol Immunol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1177\/0961203308094360","article-title":"Thrombotic thrombocytopenic purpura in systemic lupus erythematosus: Risk factors and clinical outcome: a single centre study","volume":"18","author":"Kwok","year":"2009","journal-title":"Lupus"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez435","article-title":"Classifications of scleroderma renal crisis and reconsideration of its pathophysiology","volume":"58","author":"Yamashita","year":"2019","journal-title":"Rheumatol (Oxford)"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-11-611335","article-title":"Drug-induced thrombotic microangiopathy: A systematic review of published reports","volume":"125","author":"Al-Nouri","year":"2015","journal-title":"Blood"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-017-3783-4","article-title":"Influenza-associated thrombotic microangiopathies","volume":"33","author":"Bitzan","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2021.04.012","article-title":"COVID-19 and thrombotic microangiopathies","volume":"202","author":"Tiwari","year":"2021","journal-title":"Thromb Res"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019003810","article-title":"How I treat microangiopathic hemolytic anemia in patients with cancer","volume":"137","author":"Thomas","year":"2021","journal-title":"Blood"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2016.12.009","article-title":"Patients with hypertension-associated thrombotic microangiopathy may present with complement abnormalities","volume":"91","author":"Timmermans","year":"2017","journal-title":"Kidney Int"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2018020184","article-title":"C5b9 formation on endothelial cells reflects complement defects among patients with renal thrombotic microangiopathy and severe hypertension","volume":"29","author":"Timmermans","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.13714","article-title":"Diagnostic and risk factors for complement defects in hypertensive emergency and thrombotic microangiopathy","volume":"75","author":"Timmermans","year":"2020","journal-title":"Hypertension"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2009070706","article-title":"Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations","volume":"21","author":"Fakhouri","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2017006767","article-title":"Severe reduction of free-form ADAMTS13, unbound to von willebrand factor, in plasma of patients with HELLP syndrome","volume":"1","author":"Yoshida","year":"2017","journal-title":"Blood Adv"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01781105","article-title":"Clinical outcome of thrombotic microangiopathy after living-donor liver transplantation treated with plasma exchange therapy","volume":"1","author":"Nishi","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0000000000000687","article-title":"Emerging therapeutic and preventive approaches to transplant-associated thrombotic microangiopathy","volume":"28","author":"Schoettler","year":"2021","journal-title":"Curr Opin Hematol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ekir.2020.10.009","article-title":": Complement in secondary thrombotic microangiopathy","volume":"6","author":"Palma","year":"2021","journal-title":"Kidney Int Rep"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.05780616","article-title":"Rovin, BH: Update on lupus nephritis","volume":"12","author":"Almaani","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2016.186","article-title":"Sullivan, KE: New insights into the immunopathogenesis of systemic lupus erythematosus","volume":"12","author":"Tsokos","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/BOR.0000000000000577","article-title":"Neutrophils in lupus nephritis","volume":"31","author":"Nishi","year":"2019","journal-title":"Curr Opin Rheumatol"},{"key":"B90","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.162.6.3647","article-title":"Amplification of the antibody response by C3b complexed to antigen through an ester link","volume":"162","author":"Villiers","year":"1999","journal-title":"J Immunol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1084\/jem.20022042","article-title":"The b cell receptor itself can activate complement to provide the complement receptor 1\/2 ligand required to enhance b cell immune responses in vivo","volume":"198","author":"Rossbacher","year":"2003","journal-title":"J Exp Med"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00055","article-title":"Systemic lupus erythematosus and deficiencies of early components of the complement classical pathway","volume":"7","author":"Macedo","year":"2016","journal-title":"Front Immunol"},{"key":"B93","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.158.10.4525","article-title":"C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: Complement deficiency and systemic lupus erythematosus revisited","volume":"158","author":"Korb","year":"1997","journal-title":"J Immunol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.5.2538","article-title":"C1q deficiency and autoimmunity: The effects of genetic background on disease expression","volume":"168","author":"Mitchell","year":"2002","journal-title":"J Immunol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.11.023","article-title":"Revision of the international society of Nephrology\/Renal pathology society classification for lupus nephritis: Clarification of definitions, and modified national institutes of health activity and chronicity indices","volume":"93","author":"Bajema","year":"2018","journal-title":"Kidney Int"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199709000-00003","article-title":"Renal vascular lesions in lupus nephritis","volume":"76","author":"Descombes","year":"1997","journal-title":"Med (Baltimore)"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.02870311","article-title":"Evaluation of clinical outcomes and renal vascular pathology among patients with lupus","volume":"7","author":"Barber","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1177\/0961203313520340","article-title":"Lupus vasculopathy: Diagnostic, pathogenetic and therapeutic considerations","volume":"23","author":"Gonzalez-Suarez","year":"2014","journal-title":"Lupus"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1177\/096120339400300106","article-title":"Renal biopsy in systemic lupus erythematosus: significance of glomerular thrombosis. analysis of 108 cases","volume":"3","author":"Miranda","year":"1994","journal-title":"Lupus"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2012.409","article-title":": Inclusion of renal vascular lesions in the 2003 ISN\/RPS system for classifying lupus nephritis improves renal outcome predictions","volume":"83","author":"Wu","year":"2013","journal-title":"Kidney Int"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01948","article-title":"Microthrombotic renal vascular lesions are associated to increased renal inflammatory infiltration in murine lupus nephritis","volume":"9","author":"Gonzalo-Gil","year":"2018","journal-title":"Front Immunol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00005-008-0007-4","article-title":"Experimental anti-GBM nephritis as an analytical tool for studying spontaneous lupus nephritis","volume":"56","author":"Du","year":"2008","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1172\/JCI3256","article-title":"Resistance of fc receptor- deficient mice to fatal glomerulonephritis","volume":"102","author":"Park","year":"1998","journal-title":"J Clin Invest"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1172\/JCI94039","article-title":"Neutrophil FcgammaRIIA promotes IgG-mediated glomerular neutrophil capture via Abl\/Src kinases","volume":"127","author":"Nishi","year":"2017","journal-title":"J Clin Invest"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.5.2791","article-title":"Increased susceptibility of decay-accelerating factor deficient mice to anti-glomerular basement membrane glomerulonephritis","volume":"167","author":"Sogabe","year":"2001","journal-title":"J Immunol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.11.6820","article-title":"Accelerated nephrotoxic nephritis is exacerbated in C1q-deficient mice","volume":"166","author":"Robson","year":"2001","journal-title":"J Immunol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1002\/art.21172","article-title":"Thrombosis in systemic lupus erythematosus: Congenital and acquired risk factors","volume":"53","author":"Afeltra","year":"2005","journal-title":"Arthritis Rheum"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1998.00582.x","article-title":"Binding of anticardiolipin antibodies to protein c via beta2-glycoprotein I (beta2-GPI): A possible mechanism in the inhibitory effect of antiphospholipid antibodies on the protein c system","volume":"112","author":"Atsumi","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"100733","DOI":"10.1016\/j.blre.2020.100733","article-title":"Interplay between platelets and coagulation","volume":"46","author":"Sang","year":"2021","journal-title":"Blood Rev"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200318817","article-title":"Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome","volume":"112","author":"Girardi","year":"2003","journal-title":"J Clin Invest"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018017095","article-title":"Complement C5 but not C3 is expendable for tissue factor activation by cofactor-independent antiphospholipid antibodies","volume":"2","author":"Muller-Calleja","year":"2018","journal-title":"Blood Adv"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1991.102","article-title":"Diagnostic significance of hypocomplementemia","volume":"39","author":"Hebert","year":"1991","journal-title":"Kidney Int"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.49","article-title":"The etiology of glomerulonephritis: Roles of infection and autoimmunity","volume":"86","author":"Couser","year":"2014","journal-title":"Kidney Int"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2019.07.017","article-title":"The role of complement in IgA nephropathy","volume":"114","author":"Tortajada","year":"2019","journal-title":"Mol Immunol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2013.08.004","article-title":"The role of complement in membranous nephropathy","volume":"33","author":"Ma","year":"2013","journal-title":"Semin Nephrol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-021-00882-9","article-title":"Complement activation in IgA nephropathy","volume":"43","author":"Medjeral-Thomas","year":"2021","journal-title":"Semin Immunopathol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.10131011","article-title":"Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease","volume":"7","author":"Kerlin","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-996100","article-title":"Thromboembolic risks and complications in nephrotic children","volume":"23","author":"Schlegel","year":"1997","journal-title":"Semin Thromb Hemost"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.981375\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,19]],"date-time":"2023-02-19T01:00:24Z","timestamp":1676768424000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.981375\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,14]]},"references-count":118,"alternative-id":["10.3389\/fimmu.2022.981375"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.981375","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,14]]},"article-number":"981375"}}